Form 4 holding
Director
Oncternal Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 29,673
- Estimated value
- $268,244
- Report date
- 23 Feb 2024
- Price
- $9.04
- Ownership
- By Hale BioPharma Ventures, LLC
HALE DAVID F - Director at Oncternal Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ONCT
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by HALE DAVID F since 07 Aug 2025
Reported holdings for HALE DAVID F in Oncternal Therapeutics, Inc.
Form 4 holding
Director
Oncternal Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 917
- Estimated value
- $8,290
- Report date
- 23 Feb 2024
- Price
- $9.04
- Ownership
- By Hale Trading Company
Form 4 holding
Director
Oncternal Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 714
- Estimated value
- $6,455
- Report date
- 23 Feb 2024
- Price
- $9.04
- Ownership
- Direct
Form 4 holding
Director
Oncternal Therapeutics, Inc.
- Security class
- Stock Options
- Shares / value
- 3,300
- Estimated value
- Report date
- 20 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for HALE DAVID F in Oncternal Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.